WO2002036546A3 - Alkynyl amides and their therapeutic applications - Google Patents
Alkynyl amides and their therapeutic applications Download PDFInfo
- Publication number
- WO2002036546A3 WO2002036546A3 PCT/US2001/045704 US0145704W WO0236546A3 WO 2002036546 A3 WO2002036546 A3 WO 2002036546A3 US 0145704 W US0145704 W US 0145704W WO 0236546 A3 WO0236546 A3 WO 0236546A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapeutic applications
- alkynyl amides
- alkynyl
- amides
- migraine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01989847A EP1330429A2 (en) | 2000-11-01 | 2001-10-31 | Alkynyl amides and their therapeutic applications |
AU2002228726A AU2002228726A1 (en) | 2000-11-01 | 2001-10-31 | Alkynyl amides and their therapeutic applications |
CA2427560A CA2427560C (en) | 2000-11-01 | 2001-10-31 | Alkynyl amides and their therapeutic applications |
JP2002539306A JP4115835B2 (en) | 2000-11-01 | 2001-10-31 | Alkynilamide and its therapeutic application |
MXPA03003926A MXPA03003926A (en) | 2000-11-01 | 2001-10-31 | Alkynyl amides and their therapeutic applications. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70377100A | 2000-11-01 | 2000-11-01 | |
US09/703,771 | 2000-11-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002036546A2 WO2002036546A2 (en) | 2002-05-10 |
WO2002036546A3 true WO2002036546A3 (en) | 2002-10-10 |
Family
ID=24826711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/045704 WO2002036546A2 (en) | 2000-11-01 | 2001-10-31 | Alkynyl amides and their therapeutic applications |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1330429A2 (en) |
JP (1) | JP4115835B2 (en) |
AU (1) | AU2002228726A1 (en) |
CA (1) | CA2427560C (en) |
MX (1) | MXPA03003926A (en) |
PE (1) | PE20020575A1 (en) |
UY (1) | UY26997A1 (en) |
WO (1) | WO2002036546A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005046659A2 (en) * | 2003-11-12 | 2005-05-26 | Nps Pharmaceuticals, Inc. | Migraine treatments including isovaleramide compounds and serotonin agonists |
DE102005062987A1 (en) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | New substituted propiolic acid amides, useful for treatment and prevention of e.g. pain, anxiety and panic attacks, are inhibitors of the mGluR5 receptor |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995001956A1 (en) * | 1993-07-06 | 1995-01-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
-
2001
- 2001-10-31 JP JP2002539306A patent/JP4115835B2/en not_active Expired - Fee Related
- 2001-10-31 PE PE2001001082A patent/PE20020575A1/en not_active Application Discontinuation
- 2001-10-31 EP EP01989847A patent/EP1330429A2/en not_active Withdrawn
- 2001-10-31 WO PCT/US2001/045704 patent/WO2002036546A2/en active Application Filing
- 2001-10-31 AU AU2002228726A patent/AU2002228726A1/en not_active Abandoned
- 2001-10-31 UY UY26997A patent/UY26997A1/en not_active Application Discontinuation
- 2001-10-31 CA CA2427560A patent/CA2427560C/en not_active Expired - Fee Related
- 2001-10-31 MX MXPA03003926A patent/MXPA03003926A/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995001956A1 (en) * | 1993-07-06 | 1995-01-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
Non-Patent Citations (4)
Title |
---|
ARM. KHIM. ZH., vol. 26, no. 10, - 1973, pages 837 - 842 * |
CHEMICAL ABSTRACTS, vol. 80, no. 15, 15 April 1974, Columbus, Ohio, US; abstract no. 81951n, R. S. GYULI-KEVKHYAN ET AL.: "Substituted 6-(dialkylamino)-2-hexynes" page 319; column 2; XP002204964 * |
ELMAZAR M M A ET AL: "ANTICONVULSANT AND NEUROTOXIC ACTIVITIES OF TWELVE ANALOGUES OF VALPROIC ACID", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, vol. 82, no. 12, 1 December 1993 (1993-12-01), pages 1255 - 1258, XP002026656, ISSN: 0022-3549 * |
PETER A. JACOBI ET AL.: "Studies on Corrin Synthesis. A Solution to the Introduction of Meso Substituents", JOURNAL OF ORGANIC CHEMISTRY, vol. 64, no. 6, 1999, EASTON US, pages 1778 - 1779, XP002204963 * |
Also Published As
Publication number | Publication date |
---|---|
PE20020575A1 (en) | 2002-06-25 |
JP4115835B2 (en) | 2008-07-09 |
CA2427560A1 (en) | 2002-05-10 |
WO2002036546A2 (en) | 2002-05-10 |
MXPA03003926A (en) | 2004-05-24 |
UY26997A1 (en) | 2002-07-31 |
AU2002228726A1 (en) | 2002-05-15 |
JP2004532804A (en) | 2004-10-28 |
CA2427560C (en) | 2010-12-07 |
EP1330429A2 (en) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY138966A (en) | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | |
NZ544591A (en) | Pyrrolodihydroisoquinolines as PDE10 inhibitors | |
YU63703A (en) | 6-supstituted pyrido-pyrimidines | |
WO2003005999A8 (en) | Methods of treating cytokine mediated diseases | |
AU1074702A (en) | Sulfamides as gamma-secretase inhibitors | |
CA2460939A1 (en) | Substituted pyrazolyl compounds for the treatment of inflammation | |
MXPA04002070A (en) | Substituted indazole compounds for the treatment of inflammation. | |
MXPA04000622A (en) | Pyrazolylcarboxanilides as fungicides. | |
MXPA04004064A (en) | Heteroaromatic carboxamide derivatives for the treatment of inflammation. | |
IL173377A0 (en) | Compounds for the treatment of metabolic disorders | |
WO2002040466A3 (en) | Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders | |
NO20001483L (en) | Novel NPY agonists | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
CA2461567A1 (en) | Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation | |
MY141011A (en) | Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones | |
BR0017157A (en) | 6-hydroxy-indazole derivatives for the treatment of glaucoma | |
WO2005056535A8 (en) | 1,2,3-triazole amide derivatives as inhibitors of cytokine production | |
MY138547A (en) | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists | |
WO2002065993A3 (en) | Use of aryl nitrone compounds in methods for treating neuropathic pain | |
HK1056725A1 (en) | 2-Thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry. | |
WO2003037863A3 (en) | Substituted indoles, method for production and use thereof for the inhibition of pain | |
WO2002036546A3 (en) | Alkynyl amides and their therapeutic applications | |
AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
YU22802A (en) | Isonipectoamides for the treatment of integrinmediates disorders | |
IL130642A0 (en) | N-(pyridinylamino)isoindolines and related compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002539306 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2427560 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/003926 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001989847 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001989847 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |